Vaccine delivery carriers: insights and future perspectives.
about
Peptide Vaccine: Progress and ChallengesVaccine adjuvant materials for cancer immunotherapy and control of infectious diseaseNon-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.Just-in-time vaccines: Biomineralized calcium phosphate core-immunogen shell nanoparticles induce long-lasting CD8(+) T cell responses in mice.Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.Nanovaccines : nanocarriers for antigen delivery.Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.Polio vaccination: past, present and future.Peptide Dose and/or Structure in Vaccines as a Determinant of T Cell ResponsesRecent advances in vaccine delivery.PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.Potential applications of nanoparticles in cancer immunotherapy.Current state and challenges in developing oral vaccines.Recent developments in nanocarrier-aided mucosal vaccination.Injectable and Pathogen-Mimicking Hydrogels for Enhanced Protective Immunity against Emerging and Highly Pathogenic Influenza Virus.Highly versatile immunostimulating nanocapsules for specific immune potentiation.In vitro evaluation of the internalization and toxicological profile of silica nanoparticles and submicroparticles for the design of dermal drug delivery strategies.Modulating the immune system through nanotechnology.Polymer nanomicelles for efficient mucus delivery and antigen-specific high mucosal immunity.Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques
P2860
Q26851329-4A01B29F-08E4-409F-9A7E-2872120E4D19Q35035612-5CB5022B-A73E-4761-ADE0-16FEAB923897Q35165017-0418B894-E435-4C1F-AA6E-4BF46DB73412Q37666019-883DE860-F50A-4DFA-B6E3-5321DF9B3DFBQ37671847-7E6E6953-245B-4720-AEF4-2B4246817B0FQ38082561-A092F58C-CC04-4D6D-9CE0-8B548C6CF9C4Q38335733-631F9C3A-F4CB-4CB7-B323-09176DB50AA7Q38396773-614BECDB-297D-49BE-85A7-0C33EE328AFDQ38582086-C3A29DD6-7A98-4066-9611-16C423604232Q38669255-5CC97CDF-1B20-4BD7-ACC1-AF7742F2B4D0Q38692217-89A41CC8-CAB1-497D-B510-78E005C329EDQ39015434-65FC8F28-506E-42BE-8A1E-F36996FB54ABQ39259629-A26503A3-4CDB-43A9-BB50-8D17A61034F5Q40228907-C5932F76-FEDC-435C-8900-37ADF1150994Q40526558-D147B1F1-DEF3-4A57-950E-7BE7516E2079Q42228751-439D20AD-DA96-492F-AC0D-86F82046F6ABQ48026783-380E7CE0-79D9-4A44-92CB-A3731E01B46BQ48630939-44FA41C7-DDC7-4899-BC8C-D7759D2F281DQ50908997-AEDA346D-35A9-4F9E-B685-EA29E6EC655DQ58699804-2C53AB9A-1802-492A-B4E7-62034F026B81
P2860
Vaccine delivery carriers: insights and future perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vaccine delivery carriers: insights and future perspectives.
@en
type
label
Vaccine delivery carriers: insights and future perspectives.
@en
prefLabel
Vaccine delivery carriers: insights and future perspectives.
@en
P50
P1476
Vaccine delivery carriers: insights and future perspectives
@en
P2093
P356
10.1016/J.IJPHARM.2012.04.047
P407
P577
2012-04-23T00:00:00Z